REPLIGEN RESPONDS TO COVID-19
March 30, 2020 Update:
Repligen understands and supports the vital role that our customers fill in the development and manufacture of biological drugs and vaccines. As a company, we are committed to employee health and safety, and to the continued supply of our products and services to our customers globally.
• All facilities are operational as we abide by local and national regulations
• All products are available with stated lead times
• No raw material supply disruptions are anticipated
• Commercial and technical support are available remotely, or in person if allowed